クリングルファーマ株式会社.

NEWS

お知らせ


Warning: Invalid argument supplied for foreach() in /home/r3716923/public_html/kringle-pharma.com/wp-content/themes/kringle_pharma/view/single/default.php on line 21
2008.12.03

Phase 2 initiated in Norway PDF

Kringle Pharma Initiated a Phase 2 Clinical Trial in Norway on ChronSeal®, a Recombinant Human HGF-Based Therapy for the Treatment of Skin Ulcers.